Interactions between human immunodeficiency and hepatitis C viruses.

被引:6
作者
Pol, S [1 ]
Zylberberg, H [1 ]
机构
[1] Hop Necker Enfants Malad, Unite Hepatol, F-75015 Paris, France
来源
REVUE DE MEDECINE INTERNE | 1998年 / 19卷 / 12期
关键词
human immune deficiency virus; hepatitis C virus; interferon alpha;
D O I
10.1016/S0248-8663(99)80061-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction. - Prevalence of hepatitis C virus (HCV) infection in human immunodeficiency virus (HIV)-infected subjects is around 9%, varying according to the mode of contamination. Reciprocal interactions between the two viruses have to be evaluated. Current knowledge and key points. - HCV infection is usually associated with chronic hepatitis and detectable viremia in HIV-infected patients. HIV infection enhances HCV replication, leading to more severe liver lesions and to a more rapid occurrence of cirrhosis. This underlines the need for both early diagnosis and therapy in order to avoid severe evolution of the liver disease. Future prospects and projects. - Even though the rate of long-term responses to interferon alpha is low, improvement may be expected from combined therapies, especially with combination including ribavirin. The impact of both antiretroviral triple therapy and accompanying immune restoration on natural history and treatment of HCV infection has to be assessed, as the above mentioned consensual conclusions may be modified in a near future. (C) 1998 Elsevier, Paris.
引用
收藏
页码:885 / 891
页数:7
相关论文
共 49 条
  • [1] ANDREU J, 1994, J HEPATOL, V21, P95
  • [2] HEPATITIS-C VIRUS (HCV) GENOTYPE, TISSUE HCV ANTIGENS, HEPATOCELLULAR EXPRESSION OF HLA-A,B,C, AND INTERCELLULAR ADHESION-1 MOLECULES - CLUES TO PATHOGENESIS OF HEPATOCELLULAR DAMAGE AND RESPONSE TO INTERFERON TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS-C
    BALLARDINI, G
    GROFF, P
    PONTISSO, P
    GIOSTRA, F
    FRANCESCONI, R
    LENZI, M
    ZAULI, D
    ALBERTI, A
    BIANCHI, FB
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (05) : 2067 - 2075
  • [3] RECOMBINANT INTERFERON-ALPHA FOR CHRONIC HEPATITIS-C IN PATIENTS POSITIVE FOR ANTIBODY TO HUMAN-IMMUNODEFICIENCY-VIRUS
    BOYER, N
    MARCELLIN, P
    DEGOTT, C
    DEGOS, F
    SAIMOT, AG
    ERLINGER, S
    BENHAMOU, JP
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (04) : 723 - 726
  • [4] Severe hepatitis in three AIDS patients treated with indinavir
    Brau, N
    Leaf, HL
    Wieczorek, RL
    Margolis, DM
    [J]. LANCET, 1997, 349 (9056) : 924 - 925
  • [5] *C CONS, 1997, GASTROENTEROL CLIN S, V20, P1
  • [6] CD8(+) lymphocyte responses to antiretroviral therapy of HIV infection
    Carr, A
    Emery, S
    Kelleher, A
    Law, M
    Cooper, DA
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 13 (04): : 320 - 326
  • [7] LOSS OF ANTIBODIES AGAINST HEPATITIS-C VIRUS IN HIV-SEROPOSITIVE INTRAVENOUS-DRUG-USERS
    CHAMOT, E
    HIRSCHEL, B
    WINTSCH, J
    ROBERT, CF
    GABRIEL, V
    DEGLON, JJ
    YERLY, S
    PERRIN, L
    [J]. AIDS, 1990, 4 (12) : 1275 - 1277
  • [8] Chemello L, 1995, J HEPATOL, V23, P8
  • [9] HEPATOCELLULAR-CARCINOMA
    COLOMBO, M
    [J]. JOURNAL OF HEPATOLOGY, 1992, 15 (1-2) : 225 - 236
  • [10] HIGH HEPATITIS-C VIREMIA AND IMPAIRED ANTIBODY-RESPONSE IN PATIENTS COINFECTED WITH HIV
    CRIBIER, B
    REY, D
    SCHMITT, C
    LANG, JM
    KIRN, A
    STOLLKELLER, F
    [J]. AIDS, 1995, 9 (10) : 1131 - 1136